EC
Euclidean Capital Portfolio holdings
AUM
$306M
This Quarter Return
+12.14%
1 Year Return
+16.69%
3 Year Return
+17.66%
5 Year Return
–
10 Year Return
–
AUM
$306M
AUM Growth
+$306M
(+15%)
Cap. Flow
+$5.53M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$10.1M |
Top Sells
| 1 |
RAPT Therapeutics
RAPT
|
$4.61M |
Sector Composition
| 1 | Healthcare | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $144M | 47.11% | 2,142,684 +150,800 | +8% | +$10.1M |
|
2
iShares MSCI India ETF
INDA
$9.17B
| $135M | 44.17% | 2,425,144 | – | – |
|
3
Oric Pharmaceuticals
ORIC
$994M
| $10M | 3.28% | 989,410 | – | – |
|
4
Foghorn Therapeutics
FHTX
$286M
| $7.4M | 2.42% | 1,573,761 | – | – |
|
5
PMV Pharmaceuticals
PMVP
$74.2M
| $2.79M | 0.91% | 2,627,643 | – | – |
|
6
SPDR S&P 500 ETF Trust
SPY
$658B
| $2.54M | 0.83% | 4,104 | – | – |
|
7
Alector
ALEC
$238M
| $1.83M | 0.6% | 1,307,858 | – | – |
|
8
Surrozen
SRZN
$104M
| $784K | 0.26% | 87,696 | – | – |
|
|
9
RAPT Therapeutics
RAPT
$188M
| $658K | 0.22% | 82,234 -575,665 | -88% | -$4.61M |
|
10
Tenaya Therapeutics
TNYA
$184M
| $621K | 0.2% | 1,015,705 | – | – |
|
|
11
Surrozen, Inc. Warrant
SRZNW
$71.6K
| $3.09K | ﹤0.01% | 170,833 | – | – |
|